主页文献库搜索
Phase II study of gefitinib treatment in advanced thymic malignancies.

Kurup(A),Burns(M),Dropcho(S),Pao(W),Loehre... J Clin Oncol 0000-00-00

...KRAS2 exon 2).,All 26 pts were evaluated for response and toxicity. There were 0 CRs, 1 PR (response duration = 5 months...

Correlation of EGFR and KRAS mutation status, response to epidermal growth fa...

Hussain(S),Zakowski(M F),Kris(M G),Ladanyi... J Clin Oncol 0000-00-00

...KRAS mutations, response to TKI, and survival and correlated these findings with histology as above.,NSCLC were classifi...

Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRA...

Jayasekara(Harindra),MacInnis(Robert J),Wi... Int J Cancer 0000-00-00

...KRAS+ (HR = 1.07, 95% CI: 1.00-1.15) and BRAF-/KRAS- (HR = 1.05, 95% CI: 1.00-1.11) but not BRAF+ tumors (HR = 0.89, 95%...

Biotherapy in the Adjuvant Treatment of Colorectal Cancer.

Tazi(El Mehdi),Essadi(Ismail),Boutayeb(Sab... Gastroenterology Res 0000-00-00

...KRAS populations. A better understanding of mechanisms of action of drugs, tumor biology, and predictive biomarkers are ...

ER stress protein AGR2 precedes and is involved in the regulation of pancreat...

Dumartin(L),Alrawashdeh(W),Trabulo(S M),Ra... Oncogene 0000-00-00

...KRAS wild-type normal pancreas cells, as well as in KRAS mutated pancreatic cancer cells and was essential for ER homoeo...

CIB1 contributes to oncogenic signalling by Ras via modulating the subcellula...

Zhu(W),Gliddon(B L),Jarman(K E),Moretti(P ... Oncogene 0000-00-00

...KRas. Consistent with this, we found that ectopic expression of oncogenic KRas and HRas in cells resulted in elevated CI...

Comparison of the quantification of KRAS mutations by digital PCR and E-ice-C...

Sefrioui(David),Mauger(Florence),Leclere(L... Clin Chim Acta 0000-00-00

...KRAS mutations in ccfDNA from metastatic colorectal cancer patients by E-ice-COLD-PCR with two digital PCR approaches. F...

Trametinib following disease reactivation under dabrafenib in Erdheim-Chester...

Nordmann(Thierry M),Juengling(Freimut D),R... Blood 0000-00-00

...KRAS mutation, without the presence of BRAF Accordingly, the addition of MEK-inhibiting trametinib to BRAF-inhibiting da...

Genetic ablation of Smoothened in pancreatic fibroblasts increases acinar-duc...

Liu(Xin),Pitarresi(Jason R),Cuitiño(Maria ... Genes Dev 0000-00-00

...Kras-driven pancreatic cancer progression, is currently unclear. Here we show that disruption of paracrine Hedgehog sign...

Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-muta...

Queralt(Bernardo),Cuyàs(Elisabet),Bosch-Ba... Oncotarget 0000-00-00

KRAS mutations are an established predictor of lack of response to EGFR-targeted therapies in patients with metastatic c...

上一页 936 937 938 939 940 941 942 943 944 下一页 940 / 共 953

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: [email protected]